<VariationArchive VariationID="433430" VariationName="NM_001171.6(ABCC6):c.1674del (p.Glu559fs)" VariationType="Deletion" Accession="VCV000433430" Version="6" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-14" DateCreated="2017-10-27" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="427000" VariationID="433430">
      <GeneList>
        <Gene Symbol="ABCC6" FullName="ATP binding cassette subfamily C member 6" GeneID="368" HGNC_ID="HGNC:57" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="16149565" stop="16223494" display_start="16149565" display_stop="16223494" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NT_187607.1" start="1807491" stop="1881489" display_start="1807491" display_stop="1881489" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="16243421" stop="16317327" display_start="16243421" display_stop="16317327" Strand="-" />
          </Location>
          <OMIM>603234</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001171.6(ABCC6):c.1674del (p.Glu559fs)</Name>
      <CanonicalSPDI>NC_000016.10:16188935:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="16188936" stop="16188936" display_start="16188936" display_stop="16188936" variantLength="1" positionVCF="16188935" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="16282793" stop="16282793" display_start="16282793" display_stop="16282793" variantLength="1" positionVCF="16282792" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>E559fs</ProteinChange>
      <ProteinChange>E445fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1115" sequenceAccession="LRG_1115">
            <Expression>LRG_1115:g.39682del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1115t1" sequenceAccession="LRG_1115t1">
            <Expression>LRG_1115t1:c.1674del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1115p1" sequenceAccession="LRG_1115p1" change="p.Glu559fs">
            <Expression>LRG_1115p1:p.Glu559fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001171.5" sequenceAccession="NM_001171" sequenceVersion="5" change="c.1674delC">
            <Expression>NM_001171.5:c.1674delC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.16188937del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.16188937del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.16282794del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.16282794del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007558.3" sequenceAccession="NG_007558" sequenceVersion="3" change="g.39682del">
            <Expression>NG_007558.3:g.39682del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001171.6" sequenceAccession="NM_001171" sequenceVersion="6" change="c.1674del" MANESelect="true">
            <Expression>NM_001171.6:c.1674del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001162.5" sequenceAccession="NP_001162" sequenceVersion="5" change="p.Glu559fs">
            <Expression>NP_001162.5:p.Glu559fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351800.1" sequenceAccession="NM_001351800" sequenceVersion="1" change="c.1332del">
            <Expression>NM_001351800.1:c.1332del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338729.1" sequenceAccession="NP_001338729" sequenceVersion="1" change="p.Glu445fs">
            <Expression>NP_001338729.1:p.Glu445fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_147784.1" sequenceAccession="NR_147784" sequenceVersion="1" change="n.1711del">
            <Expression>NR_147784.1:n.1711del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1313008538" DB="dbSNP" />
        <XRef ID="CA394889441" DB="ClinGen" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001171.6(ABCC6):c.1674del (p.Glu559fs) AND Autosomal recessive inherited pseudoxanthoma elasticum" Accession="RCV000499256" Version="3">
        <ClassifiedConditionList TraitSetID="1820">
          <ClassifiedCondition DB="MedGen" ID="C1275116">Autosomal recessive inherited pseudoxanthoma elasticum</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-03-02" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001171.6(ABCC6):c.1674del (p.Glu559fs) AND multiple conditions" Accession="RCV002490821" Version="1">
        <ClassifiedConditionList TraitSetID="12598">
          <ClassifiedCondition DB="MedGen" ID="C3276161">Arterial calcification, generalized, of infancy, 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1275116">Autosomal recessive inherited pseudoxanthoma elasticum</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1867450">Pseudoxanthoma elasticum, forme fruste</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001171.6(ABCC6):c.1674del (p.Glu559fs) AND not provided" Accession="RCV002524119" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-08" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-10-27" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11536079</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17617515</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18157818</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-31">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-03-07">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3552" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Gronblad Strandberg syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive inherited pseudoxanthoma elasticum</ElementValue>
                <XRef ID="MONDO:0009925" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PXE</ElementValue>
                <XRef Type="MIM" ID="264800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9643" />
                <XRef ID="9643" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Pseudoxanthoma elasticum (PXE) is a systemic disorder that affects the elastic tissue of the skin, the eye, and vascular system. Individuals most commonly present with angioid streaks of the retina found on routine eye examination or associated with retinal hemorrhage and/or characteristic papules in the skin. The most frequent cause of morbidity and disability in PXE is reduced vision due to complications of subretinal neovascularizations and macular atrophy. Other manifestations include premature gastrointestinal angina and/or bleeding, intermittent claudication of arm and leg muscles, stroke, renovascular hypertension, and cardiovascular complications (angina/myocardial infarction). Most affected individuals live a normal life span.</Attribute>
                <XRef ID="NBK1113" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301292</ID>
                <ID Source="BookShelf">NBK1113</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Uitto et al., 2012">
                <ID Source="pmc">3121926</ID>
              </Citation>
              <XRef ID="758" DB="Orphanet" />
              <XRef ID="C1275116" DB="MedGen" />
              <XRef ID="MONDO:0009925" DB="MONDO" />
              <XRef Type="MIM" ID="264800" DB="OMIM" />
            </Trait>
            <Trait ID="3553" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Pseudoxanthoma elasticum, forme fruste</ElementValue>
                <XRef ID="MONDO:0008333" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PSEUDOXANTHOMA ELASTICUM, HETEROZYGOUS</ElementValue>
                <XRef ID="177850" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pseudoxanthoma Elasticum, Incomplete</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="exclude from dictionary">Excluding this from the dictionary per request from Sharon Terry.</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Pseudoxanthoma elasticum (PXE) is a systemic disorder that affects the elastic tissue of the skin, the eye, and vascular system. Individuals most commonly present with angioid streaks of the retina found on routine eye examination or associated with retinal hemorrhage and/or characteristic papules in the skin. The most frequent cause of morbidity and disability in PXE is reduced vision due to complications of subretinal neovascularizations and macular atrophy. Other manifestations include premature gastrointestinal angina and/or bleeding, intermittent claudication of arm and leg muscles, stroke, renovascular hypertension, and cardiovascular complications (angina/myocardial infarction). Most affected individuals live a normal life span.</Attribute>
                <XRef ID="NBK1113" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10104" />
                <XRef ID="10104" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301292</ID>
                <ID Source="BookShelf">NBK1113</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Uitto et al., 2012">
                <ID Source="pmc">3121926</ID>
              </Citation>
              <XRef ID="758" DB="Orphanet" />
              <XRef ID="C1867450" DB="MedGen" />
              <XRef ID="MONDO:0008333" DB="MONDO" />
              <XRef Type="MIM" ID="177850" DB="OMIM" />
            </Trait>
            <Trait ID="16820" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Arterial calcification, generalized, of infancy, 2</ElementValue>
                <XRef ID="MONDO:0013768" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GACI2</ElementValue>
                <XRef Type="MIM" ID="614473" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Generalized arterial calcification of infancy (GACI) is characterized by infantile onset of widespread arterial calcification and/or narrowing of large and medium-sized vessels resulting in cardiovascular findings (which can include heart failure, respiratory distress, edema, cyanosis, hypertension, and/or cardiomegaly). Additional findings can include typical skin and retinal manifestations of pseudoxanthoma elasticum (PXE), periarticular calcifications, development of rickets after infancy, cervical spine fusion, and hearing loss. While mortality in infancy is high, survival into the third and fourth decades has occurred.</Attribute>
                <XRef ID="NBK253403" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25392903</ID>
                <ID Source="BookShelf">NBK253403</ID>
              </Citation>
              <XRef ID="51608" DB="Orphanet" />
              <XRef ID="C3276161" DB="MedGen" />
              <XRef ID="MONDO:0013768" DB="MONDO" />
              <XRef Type="MIM" ID="614473" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1820" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3552" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Gronblad Strandberg syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive inherited pseudoxanthoma elasticum</ElementValue>
                <XRef ID="MONDO:0009925" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PXE</ElementValue>
                <XRef Type="MIM" ID="264800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9643" />
                <XRef ID="9643" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Pseudoxanthoma elasticum (PXE) is a systemic disorder that affects the elastic tissue of the skin, the eye, and vascular system. Individuals most commonly present with angioid streaks of the retina found on routine eye examination or associated with retinal hemorrhage and/or characteristic papules in the skin. The most frequent cause of morbidity and disability in PXE is reduced vision due to complications of subretinal neovascularizations and macular atrophy. Other manifestations include premature gastrointestinal angina and/or bleeding, intermittent claudication of arm and leg muscles, stroke, renovascular hypertension, and cardiovascular complications (angina/myocardial infarction). Most affected individuals live a normal life span.</Attribute>
                <XRef ID="NBK1113" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301292</ID>
                <ID Source="BookShelf">NBK1113</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Uitto et al., 2012">
                <ID Source="pmc">3121926</ID>
              </Citation>
              <XRef ID="758" DB="Orphanet" />
              <XRef ID="C1275116" DB="MedGen" />
              <XRef ID="MONDO:0009925" DB="MONDO" />
              <XRef Type="MIM" ID="264800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1146904" SubmissionDate="2021-03-02" DateLastUpdated="2021-03-07" DateCreated="2017-10-27">
        <ClinVarSubmissionID localKey="c.1674delC" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV000589194" DateUpdated="2021-03-07" DateCreated="2017-10-27" Type="SCV" Version="2" SubmitterName="PXE International" OrgID="500195" OrganizationCategory="consortium" OrgAbbreviation="PXE" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">18157818</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Submitter's publication</Attribute>
          <Citation>
            <ID Source="PubMed">18157818</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <Citation>
              <ID Source="PubMed">18157818</ID>
            </Citation>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ABCC6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001171.5:c.1674delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="264800" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5443761" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_001171.6:c.1674del|OMIM:177850;264800;614473" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002792817" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001171.6:c.1674del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="177850" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="264800" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614473" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6131683" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4930337|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003443497" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18157818</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11536079</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17617515</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 433430). This premature translational stop signal has been observed in individual(s) with pseudoxanthoma elasticum (PMID: 18157818). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu559Argfs*4) in the ABCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCC6 are known to be pathogenic (PMID: 11536079, 17617515).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ABCC6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.16282793del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5443761" TraitType="Disease" MappingType="XRef" MappingValue="614473" MappingRef="OMIM">
        <MedGen CUI="C3276161" Name="Arterial calcification, generalized, of infancy, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1146904" TraitType="Disease" MappingType="XRef" MappingValue="264800" MappingRef="OMIM">
        <MedGen CUI="C1275116" Name="Autosomal recessive inherited pseudoxanthoma elasticum" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5443761" TraitType="Disease" MappingType="XRef" MappingValue="177850" MappingRef="OMIM">
        <MedGen CUI="C1867450" Name="Pseudoxanthoma elasticum, forme fruste" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6131683" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5443761" TraitType="Disease" MappingType="XRef" MappingValue="264800" MappingRef="OMIM">
        <MedGen CUI="C1275116" Name="Autosomal recessive inherited pseudoxanthoma elasticum" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

